

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and inv...
Q2 2026
Aug 13, 2026
Q1 2026
May 7, 2026
FY 2025
Mar 12, 2026
Q4 2025
Mar 12, 2026
Q3 2025
Nov 12, 2025